http://www.freshnews.com/news/biotech-biomedical/ California Tech News Updated Daily! BioTech / BioMedical / Medical en-us Sun, 07 Sep 2008 10:20:02 -0700 1000 http://www.freshnews.com/news/biotech-biomedical/article_45166.html 2008-09-05 Gen-Probe Incorporated (NASDAQ:GPRO) announced today that the Company will present at the Morgan Stanley Global Healthcare Unplugged Conference on Tuesday, September 9, 2008 at approximately 2:45 p.m. Eastern Time. The presentation is scheduled to be webcast live and may be accessed through a link on the investors section of... http://www.freshnews.com/news/biotech-biomedical/article_45163.html 2008-09-05 ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it filed a registration statement as required under the terms of its previously announced Committed Equity Financing Facility (CEFF) with Kingsbridge Capital... http://www.freshnews.com/news/biotech-biomedical/article_45158.html 2008-09-05 Digirad Corporation (NASDAQ:DRAD), a leading provider of medical diagnostic imaging systems and services to physicians' offices, hospitals and imaging centers, today announced the initial clinical trial of a new imaging system incorporating new proprietary technology to correct attenuation, or image distortion, an inherent issue in cardiac SPECT imaging. Cardiac SPECT (single... http://www.freshnews.com/news/biotech-biomedical/article_45150.html 2008-09-04 ZyGEM Corp. Ltd. Today announced that it has entered into a collaboration with Commonwealth Biotechnologies, Inc. (CBI) (NASDAQ:CBTE) to further evaluate and use ZyGEM's forensicGEM DNA extraction technology in CBI's forensic operations. The collaboration will also combine ZyGEM's innovative technologies and CBI's forensic expertise to develop additional products... http://www.freshnews.com/news/biotech-biomedical/article_45135.html 2008-09-04 Aethlon Medical, Inc. (OTCBB:AEMD) disclosed today that its Chairman and CEO, James A. Joyce has issued the following letter to shareholders. To our Shareholders, September 2008 will be a pivotal month for our organization as we expect to initiate the first clinical use of our Hemopurifier in HIV-infected individuals. We believe... http://www.freshnews.com/news/biotech-biomedical/article_45130.html 2008-09-04 Cypress Bioscience, Inc. (NASDAQ: CYPB) today announced that Michael R. Hufford, PhD, its Vice President of Corporate Development, will participate in Citi's Biotech Day on September 8, 2008. The Citi conference is being held at Citi's Executive Conference Center in New York, NY. Dr. Hufford is scheduled to give a... http://www.freshnews.com/news/biotech-biomedical/article_45122.html 2008-09-04 CliniComp, Intl., a leading provider of intelligent inpatient electronic medical record and clinical surveillance solutions, today announced an agreement to provide the Essentris Perinatal Solution to Tenet Healthcare Corporation (NYSE:THC), one of the country’s major health systems. Dallas-based Tenet initially will deploy CliniComp’s Essentris Perinatal in the labor and delivery (L&D)... http://www.freshnews.com/news/biotech-biomedical/article_45120.html 2008-09-04 Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced that it has signed non-exclusive agreements with New England Biolabs, Inc., QIAGEN GmbH, and Kirkegaard & Perry Laboratories, Inc. (KPL), whereby the companies have licensed Invitrogen’s patented technology covering the random prime amplification... http://www.freshnews.com/news/biotech-biomedical/article_45119.html 2008-09-04 Isis Pharmaceuticals, Inc. (Nasdaq: ISIS), Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), and the companies’ joint venture Regulus Therapeutics LLC, announced today that the United States Patent and Trademark Office (USPTO) has granted notices of allowance for two U.S. patent applications that further enhance the scope of Isis’ “Crooke” patent estate, which... http://www.freshnews.com/news/biotech-biomedical/article_45115.html 2008-09-03 NuVasive, Inc. (NASDAQ:NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today that Alex Lukianov, Chairman and Chief Executive Officer, is scheduled to present at the Bank of America 38th Annual Investment Conference at The Ritz Carlton Hotel, San Francisco, CA... http://www.freshnews.com/news/biotech-biomedical/article_45109.html 2008-09-03 The Emergen-C PINK Keep A Breast Tour will travel throughout California October 9th to 18th, making stops at five college campuses to stress the importance of early detection and prevention of breast cancer. In partnership with The Keep A Breast Foundation and Roxy, Emergen-C PINK will be providing students... http://www.freshnews.com/news/biotech-biomedical/article_45108.html 2008-09-03 Nventa Biopharmaceuticals Corporation (TSX: NVN) today announced that the company will present corporate updates at a number of upcoming industry and financial conferences. Nventa's presentations will focus on HspE7, the company's lead product candidate for the treatment of human papillomavirus (HPV)-related diseases, as well as the company's proprietary Toll-like... http://www.freshnews.com/news/biotech-biomedical/article_45106.html 2008-09-03 Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced positive safety and efficacy results from its third Phase II clinical trial using its proprietary, orally-active nonpeptide Gonadotropin-Releasing Hormone (GnRH) receptor antagonist, elagolix, in patients with endometriosis. The PETAL study enrolled 252 patients, with a confirmed diagnosis of endometriosis, into three treatment groups;... http://www.freshnews.com/news/biotech-biomedical/article_45092.html 2008-09-02 Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced positive safety and efficacy results from its third Phase II clinical trial using its proprietary, orally-active nonpeptide Gonadotropin-Releasing Hormone (GnRH) receptor antagonist, elagolix, in patients with endometriosis. The PETAL study enrolled 252 patients, with a confirmed diagnosis of endometriosis, into three treatment groups;... http://www.freshnews.com/news/biotech-biomedical/article_45090.html 2008-09-02 Ablation Frontiers, Inc., announced today that two important studies, involving its innovative atrial fibrillation ablation products were presented by Dr. Lucas Boersma of the St. Antonius Hospital in Nieuwegein, Netherlands at the European Society of Cardiology (ESC) congress. One of the world's most prestigious scientific meetings for cardiologists, the... http://www.freshnews.com/news/biotech-biomedical/article_45088.html 2008-09-02 NuVasive, Inc. (NASDAQ:NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today that Alex Lukianov, Chairman and Chief Executive Officer, and Kevin O'Boyle, Executive Vice President and Chief Financial Officer, are scheduled to present at the Morgan Stanley Global Healthcare Unplugged... http://www.freshnews.com/news/biotech-biomedical/article_45080.html 2008-09-02 Somaxon Pharmaceuticals, Inc. (Nasdaq:SOMX), a specialty pharmaceutical company focused on the in-licensing and development of proprietary product candidates for the treatment of diseases and disorders in the fields of psychiatry and neurology, today announced that data from a pharmacological profiling study relating to doxepin, the active ingredient in the company’s... http://www.freshnews.com/news/biotech-biomedical/article_45079.html 2008-09-02 NuVasive, Inc. (NASDAQ:NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today that Alex Lukianov, Chairman and Chief Executive Officer, and Kevin O'Boyle, Executive Vice President and Chief Financial Officer, are scheduled to present at the Thomas Weisel Partners Healthcare Conference... http://www.freshnews.com/news/biotech-biomedical/article_45073.html 2008-09-02 Volcano Corporation (NASDAQ:VOLC) [ESC Booth # A2-D403], a leading manufacturer of intravascular ultrasound (IVUS) and functional measurement (FM) technology, announced today the use of its VH(R) IVUS (Virtual Histology IVUS) in GlaxoSmithKline's IBIS-2 trial (Integrated Biomarker and Imaging Study). In the study, Volcano's VH(R) IVUS technology demonstrated and quantified... http://www.freshnews.com/news/biotech-biomedical/article_45062.html 2008-09-02 Sequenom, Inc. (NASDAQ:SQNM), a leading provider of genetic analysis solutions, today announced the Company will present at three investment conferences and will hold an analyst day event in September. The presentations are as follows: * Thomas Weisel Partners Healthcare Conference 2008 Wednesday, September 3, at 10:55 a.m. Eastern time.... http://www.freshnews.com/news/biotech-biomedical/article_45061.html 2008-09-02 Aethlon Medical, Inc. (OTCBB:AEMD) today announced that Chairman and Chief Executive Officer, James A. Joyce, will present a company overview at the California Stock Report’s 2008 Southern California Investor Conference being held tomorrow, September 3rd, at The Island Hotel in Newport Beach, California. A live audio webcast of the... http://www.freshnews.com/news/biotech-biomedical/article_45059.html 2008-09-02 Optimer Pharmaceuticals, Inc. (Nasdaq:OPTR) today announced that the company has completed enrollment in the second of two planned phase 3 clinical trials evaluating the safety and efficacy of Prulifloxacin for the treatment of infectious diarrhea in travelers. The Company previously reported positive top-line data from the first Phase 3... http://www.freshnews.com/news/biotech-biomedical/article_45057.html 2008-09-02 Burnham Institute for Medical Research (Burnham) announced today that it has been awarded a prestigious six-year, $97.9 million Molecular Libraries Probe Production Centers Network (MLPCN) grant from the National Institutes of Health (NIH). Burnham will equip and manage one of four comprehensive small-molecule screening and discovery centers in the nation....